Emerging Infectious Diseases

Journal Title：Emerging Infectious Diseases

Emerging Infectious Diseases is an open-access, peer-reviewed journal published monthly by the Centers for Disease Control and Prevention (CDC). Note that beginning with Volume 26, the journal began publishing online-only. Publication in EID enables compliance with the NIH Public Access Policy.

Emerging Infectious Diseases follows the International Committee of Medical Journal Editors recommendations for the conduct, reporting, editing, and publishing of scholarly work in medical journals. The journal’s peer review process allows for critical assessment of submitted manuscripts by experts who are usually not part of its editorial staff. As an independent publication, the journal’s peer-review process operates independently from CDC’s clearance processes.

The conclusions, findings, and opinions expressed by authors contributing to Emerging Infectious Diseases do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by the Public Health Service or by the U.S. Department of Health and Human Services.

《新發傳染病》是一份開放獲取、同行評審的期刊，由美國疾病控制與預防中心 (CDC) 每月出版。請注意，從第 26 卷開始，該期刊開始僅在線出版。在 EID 上出版符合 NIH 公共訪問政策。

《新發傳染病》遵循國際醫學期刊編輯委員會關于在醫學期刊上開展、報告、編輯和出版學術工作的建議。該期刊的同行評審流程允許通常不屬于其編輯人員的專家對提交的稿件進行批判性評估。作為獨立出版物，該期刊的同行評審流程獨立于 CDC 的審批流程。

《新發傳染病》作者所表達的結論、發現和觀點不一定反映美國衛生與公眾服務部、公共衛生服務部、疾病控制與預防中心或作者所屬機構的官方立場。使用商標名僅用于識別，并不意味著獲得美國公共衛生服務部或美國衛生與公眾服務部的認可。

Emerging Infectious Diseases創刊于1995年，由Centers for Disease Control and Prevention (CDC)出版商出版，收稿方向涵蓋醫學 - 傳染病學全領域，此刊是該細分領域中屬于非常不錯的SCI期刊，在行業細分領域中學術影響力較大，專業度認可很高，所以對原創文章要求創新性較高，如果您的文章質量很高，可以嘗試。平均審稿速度 約1.0個月 ，影響因子指數7.2，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。